$ Value
$0
Shares
17,806
Price
$0
Filed
Mar 3
Insider
Name
Carlisle Cynthia
Title
Executive Vice President, CHRO
CIK
0002013998
Roles
Transaction Details
Transaction Date
2026-02-27
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
17,806
Footnotes
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan (the "Plan"). | The reporting person received a grant of 11,871 restricted stock units all of which are scheduled to vest on February 27, 2029, subject to satisfaction of the related vesting requirements set forth in the Plan. | The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
Filing Info
Carlisle Cynthia's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-27 | BAX | A | $0 |
| 2026-02-27 | BAX | A | $0 |
| 2026-02-27 | BAX | A | $0 |
| 2025-09-08 | FL | A | $0 |
| 2025-09-08 | FL | D | — |
| 2025-09-08 | FL | D | — |
Other Insiders at BAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| McDonnell Michael R. | — | — | 2026-02-13 |
|
Grade Joel T.
EVP and CFO
|
— | — | 2026-03-06 |
|
Zielinski Anita A
SVP, CAO and Controller
|
— | — | 2026-03-06 |
|
Rosenbloom David S.
EVP and General Counsel
|
— | — | 2026-03-06 |
|
Hider Andrew P.
President and CEO
|
— | — | 2026-02-27 |
|
Rasul Reazur
EVP,Group Pres,Healthcare
|
— | — | 2026-03-06 |
|
Carlisle Cynthia
Executive Vice President, CHRO
|
— | — | 2026-02-27 |
|
Soriano Maria Cecilia
Group Pres., ITT & Pharma.
|
— | — | 2026-03-06 |